20/20 BioLabs
NASDAQ: AIDXMaryland, US · 2 known investors
20/20 BioLabs develops AI-powered blood tests for early detection of multiple cancers and chronic diseases, using protein tumor markers and machine learning. The company offers affordable, at-home collection tests starting under $200, targeting individuals and healthcare providers seeking early disease detection.
BiotechDigital HealthHealthtech
Founders & leadership
MC
Mr. CohenFounder, Chief Executive Officer, President
DL
Dr. LebowitzChief Scientific Officer
DZ
Dr. Zhou